24
19
1
49
2
2
2c
1b
1d
18
36
63
1d
2 29
1d
25
Emily Bryer Tomasulo, DO
88
63
Assistant Professor of Clinical Medicine (Hematology-Oncology)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
60
4
3
3
3
2
4
b
1f
60
230 W Washington Square
Philadelphia, PA 19106
26
Philadelphia, PA 19106
35
f
13
Education:
21 7 BS 54 (Spanish Major, Minors in Psychology and Biology, Honors in Neuroscience) c
55 Schreyer Honors College of The Pennsylvania State University, 2013.
21 7 DO 16 (Medicine ) c
45 Philadelphia College of Osteopathic Medicine, 2017.
c
3
3
3
3
8d
Permanent link21 7 BS 54 (Spanish Major, Minors in Psychology and Biology, Honors in Neuroscience) c
55 Schreyer Honors College of The Pennsylvania State University, 2013.
21 7 DO 16 (Medicine ) c
45 Philadelphia College of Osteopathic Medicine, 2017.
c
2 29
21
1e
1d
24
2b
29
27
23
19a Emily Tomasulo, Andy Itsara, Mark Haigney, Douglas R. Rosing, Inhye E. Ahn, Cody Peer, Beth A. Kozel, Teresa Luperchio, Grace Ge, William D. Figg, Adrian Wiestner, and Clare Sun: Sudden Death and Asymptomatic Arrhythmia in CLL Patients Treated with Ibrutinib. Heart Rhythm October 2025 Notes: https://doi.org/10.1016/j.hrthm.2025.10.014.
178 Christopher Pleyer, Emily Tomasulo, et. al: Activity and Safety of Venetoclax without Anti-CD20 Lead-in Therapy in Treatment Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood Supplement, American Society of Hematology Annual Meeting, San Diego, CA. Dec 2024 Notes: "Poster Presentation"
103 Emily B. Tomasulo, Dylan Therwhanger, Emeline R. Chong, Mitchell E. Hughes, Michael Fradley, and Stephen J. Schuster: Resolution of ibrutinib-associated hypertension with transition to alternate covalent BTKi 8e Blood Supplement, American Society of Hematology Annual Meeting, San Diego, CA. Dec 2024 Notes: "Poster Presentation"
14e Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun: Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL. Leukemia & Lymphoma 64(14): 2306-2315. Dec 2023.
143 Itsara A, Sun C, Bryer E, et al. : Long-Term Outcomes in Chronic Lymphocytic Leukemia Treated with Ibrutinib: 10-Year Follow-up of a Phase 2 Study. Blood Supplement, American Society of Hematology, Washington, DC Dec 2023 Notes: "Poster Presentation"
67 Emily Tomasulo: Chronic Lymphocytic Leukemia Chapter 3e Bethesda Handbook of Hematology 2023.
10e Bryer E, Itsara A, Ahn I et al.: Ibrutinib-associated sudden death in patients with CLL. Blood, American Society of Hematology, Orlando, FL. 140(Supplement 1), Dec 2022 Notes: "Poster Presentation"
d8 Bryer EJ, Destefano C, Kazandjian D.: Current and prospective antibody-based therapies in multiple myeloma Semin Oncol 49(1): 41-47, Feb 2022.
122 Bryer EJ, Stein E, Goldberg S.: Multivessel Coronary Artery Disease. Mayo Clinic Proceedings: Innovations, Quality, and Outcomes. Dec 2020 Notes: https://mcpiqojournal.org/action/showPdf?pii=S2542-4548%2820%2930150-8.
2c
7
1d
1f
Selected Publications
ce Chong EA, Tomasulo EB, Barta SK: 2026 Update on the Management of Diffuse Large B-Cell Lymphoma. American Journal of Hematology 2026.19a Emily Tomasulo, Andy Itsara, Mark Haigney, Douglas R. Rosing, Inhye E. Ahn, Cody Peer, Beth A. Kozel, Teresa Luperchio, Grace Ge, William D. Figg, Adrian Wiestner, and Clare Sun: Sudden Death and Asymptomatic Arrhythmia in CLL Patients Treated with Ibrutinib. Heart Rhythm October 2025 Notes: https://doi.org/10.1016/j.hrthm.2025.10.014.
178 Christopher Pleyer, Emily Tomasulo, et. al: Activity and Safety of Venetoclax without Anti-CD20 Lead-in Therapy in Treatment Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood Supplement, American Society of Hematology Annual Meeting, San Diego, CA. Dec 2024 Notes: "Poster Presentation"
103 Emily B. Tomasulo, Dylan Therwhanger, Emeline R. Chong, Mitchell E. Hughes, Michael Fradley, and Stephen J. Schuster: Resolution of ibrutinib-associated hypertension with transition to alternate covalent BTKi 8e Blood Supplement, American Society of Hematology Annual Meeting, San Diego, CA. Dec 2024 Notes: "Poster Presentation"
14e Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun: Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL. Leukemia & Lymphoma 64(14): 2306-2315. Dec 2023.
143 Itsara A, Sun C, Bryer E, et al. : Long-Term Outcomes in Chronic Lymphocytic Leukemia Treated with Ibrutinib: 10-Year Follow-up of a Phase 2 Study. Blood Supplement, American Society of Hematology, Washington, DC Dec 2023 Notes: "Poster Presentation"
67 Emily Tomasulo: Chronic Lymphocytic Leukemia Chapter 3e Bethesda Handbook of Hematology 2023.
10e Bryer E, Itsara A, Ahn I et al.: Ibrutinib-associated sudden death in patients with CLL. Blood, American Society of Hematology, Orlando, FL. 140(Supplement 1), Dec 2022 Notes: "Poster Presentation"
d8 Bryer EJ, Destefano C, Kazandjian D.: Current and prospective antibody-based therapies in multiple myeloma Semin Oncol 49(1): 41-47, Feb 2022.
122 Bryer EJ, Stein E, Goldberg S.: Multivessel Coronary Artery Disease. Mayo Clinic Proceedings: Innovations, Quality, and Outcomes. Dec 2020 Notes: https://mcpiqojournal.org/action/showPdf?pii=S2542-4548%2820%2930150-8.
2c
44
23
Back to Top
1b
1d
18